Exciting Times in the World of Proteomics! Thermo Fisher Scientific’s remarkable $3.1 billion acquisition of Olink Proteomics is a testament to the incredible technology that forms the foundation of Olink Proteomics. Olink’s advancements in proteomics have significant impacts on both ongoing drug discovery and future precision medicine. Navinci and Olink Proteomics share the same ancestry,…
Expanding our reach – new distribution partnership in Italy Navinci is excited to announce a distribution collaboration with EuroClone, a strategic move aimed at advancing our global sales expansion efforts. This partnership will enable us to bring Naveni® Proximity Ligation Assay kits to the Italian life science research and pharma industry. EuroClone is renowned for its extensive distribution network, market reach, and…
New Research Unveils p53 Aggregates’ Vital Role in Ovarian Cancer Prognosis and Treatment Strategies Nicole Heinzl at the Medical University of Vienna, Vienna, Austria has, together with co-authors, recently published a study in Oncogene. The authors used our NaveniFlex™ assay for the studies, and we are very proud that our research tools proved to be…
CICON-23, 20-23 September, Milan Italy Doroteya Raykova will present our poster Unraveling the tumor microenvironment with spatial proteomics: in situ detection of immune checkpoint interactions in cancer patient tissues (PDF) at the CICON-23 Conference. Inge Cyrén, Area Manager for North America will also be representing Navinci. Please reach out to them if you want to book a…
Expanding Your Options with NaveniLink™ Would you like to perform a proximity ligation assay using your own primary antibodies? Our NaveniLink conjugation kit allows you to do just that. You can use your primary antibodies and easily conjugate them with our proprietary oligonucleotide sequences. These conjugates can be seamlessly integrated into our Naveni® product line,…
Product Advancement: NaveniFlex™ Cell We know that diverse sample types demand tailored solutions. To maximize the value of your samples, we refined and optimized our Flexible offerings and aligned them closer to your needs. Introducing NaveniFlex Cell, an optimized advancement that builds upon the strong foundation of our NaveniFlex™ technology. This cutting-edge kit is meticulously…
NaveniFlex in Autophagy publication We’re excited to see that our Naveni® technology has been referenced in a fantastic publication describing novel insights into the process of lysosomal degradation of mitochondria (mitophagy) (Godtliebsen et al. 2023, Autophagy). The authors used ingenious double tagging of mitochondria, where the green signal was quenched at low pH, whereas red…
Cayman and Navinci Announce Strategic Partnership Expanding Access to Next-Generation Tools for Spatial Proteomics Ann Arbor, MI – 07/05/2023 – Global life sciences supplier Cayman Chemical (Cayman) announced today a strategic partnership with Navinci Diagnostics (Navinci), a Swedish biotechnology company developing innovative tools for spatial proteomics. This partnership expands access to Navinci’s portfolio of proximity…